Lina_S

About Lina Silva Salinas

This author has not yet filled in any details.
So far Lina Silva Salinas has created 407 blog entries.

“You have to be sure that the patient has the full picture”: Adaptation of the Best Case/Worst Case communication tool for geriatric oncology

2022-02-03T10:05:21+01:00

Melisa L. Wong, Francesca M. Nicosia, Alexander K. Smith, Louise C. Walter, Vivian Lam, Harvey Jay Cohen, Kah Poh Loh, Supriya G. Mohile, Carling J. Ursem, Margaret L. Schwarze. Published:February 02, 2022 DOI:https://doi.org/10.1016/j.jgo.2022.01.014

“You have to be sure that the patient has the full picture”: Adaptation of the Best Case/Worst Case communication tool for geriatric oncology2022-02-03T10:05:21+01:00

Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial

2022-01-31T08:11:31+01:00

Lissandra Dal Lago, Aimé Lambert Uwimana, Corneel Coens, Peter Vuylsteke, Giuseppe Curigliano, Barbara Brouwers, Agnieszka Jagiello-Gruszfeld, Sevilay Altintas, Konstantinos Tryfonidis, Coralie Poncet, Andrew Bottomley, Berta Sousa, Etienne Brain, Hans Wildiers. Published:January 28, 2022 DOI:https://doi.org/10.1016/j.jgo.2022.01.009

Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial2022-01-31T08:11:31+01:00

Systemic treatment for triple negative breast cancer in older patients: A Young International Society of Geriatric Oncology Review Paper

2022-01-24T08:26:04+01:00

Wing-Lok Chan, Joana Marinho, Yanin Chavarri-Guerra, Jacobo Hincapie-Echeverri, Rogelio N. Velasco, Baran Akagunduz, Mukul Roy, Wing Tung Gobby Kwong, Wing-Fong Wu, Nicolò Matteo Luca Battisti, Enrique Soto-Perez-de-Celis.Journal of Geriatric Oncology. Available online 23 January 2022

Systemic treatment for triple negative breast cancer in older patients: A Young International Society of Geriatric Oncology Review Paper2022-01-24T08:26:04+01:00

Wearable sensors and at-home biospecimen collection supports older adults participation in clinical trials

2022-01-31T08:06:53+01:00

Older adults are underrepresented in cancer clinical trials1,2. Though some are excluded due to having more comorbidities than their younger counterparts, others decline participation because of an already high healthcare burden.

Wearable sensors and at-home biospecimen collection supports older adults participation in clinical trials2022-01-31T08:06:53+01:00

Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years.

2022-01-13T11:08:31+01:00

Demetris Papamichael, Guilherme S. Lopes, Curt L. Olswold, Jean-Yves Douillard, Richard A. Adams, Timothy S. Maughan, Eric Van Cutsem, Alan P. Venook, Heinz-Josef Lenz, Volker Heinemann, Richard Kaplan, Carsten Bokemeyer, Benoist Chibaudel, Axel Grothey, Takayuki Yoshino, John Zalcberg, Aimery De Gramont, Qian Shib. Eur J Cancer 2022; 163: 1-15

Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years.2022-01-13T11:08:31+01:00

Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer – Results from a prospective phase IV clinical trial

2022-01-04T09:29:02+01:00

Johannes Betge, Nadine Schulte, Sebastian Belle, Tianzuo Zhan, Beate Krammer-Steiner, Jean-Charles Moulin, Matthias Kleiß, Frank Lammert, Ulrich Wedding, Sebastian Räth, Martin Maenz, Lisa Hegele, Julian Larcher-Senn, Ralf Jesenofsky, Matthias P. Ebert, Nicolai Härtel. Published: January 03, 2022 DOI: https://doi.org/10.1016/j.jgo.2021.12.018.

Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer – Results from a prospective phase IV clinical trial2022-01-04T09:29:02+01:00

Pre-treatment neutrophil to lymphocyte ratio as a biomarker of frailty and predictor of survival among older adults with multiple myeloma

2021-12-20T08:15:04+01:00

Smith Giri, Sumit Dahal, Susan Bal, Kelly N. Godby, Joshua Richman, Adam J. Olszewski, Grant R. Williams, Cynthia Brown, Thomas W. Buford, Luciano J. Costa, Smita Bhatia. Published: December 17, 2021 DOI: https://doi.org/10.1016/j.jgo.2021.12.004

Pre-treatment neutrophil to lymphocyte ratio as a biomarker of frailty and predictor of survival among older adults with multiple myeloma2021-12-20T08:15:04+01:00

An overview of chemotherapy toxicity prediction tools in older adults with cancer: A young international society of geriatric oncology and nursing and allied health initiative

2021-12-16T09:43:19+01:00

Nicolò Matteo Luca Battisti, Sukeshi Patel Arora. Published: December 15, 2021DOI:https://doi.org/10.1016/j.jgo.2021.12.006

An overview of chemotherapy toxicity prediction tools in older adults with cancer: A young international society of geriatric oncology and nursing and allied health initiative2021-12-16T09:43:19+01:00
Go to Top